New knowledge on critical osteoclast formation and activation pathways from study of rare genetic diseases of osteoclasts: focus on the RANK/RANKL axis.
Functional, biochemical and genetic studies have over the past decade identified many causative genes in the osteoclast diseases osteopetrosis and Paget's disease of bone. Here, we outline all osteoclast diseases and their genetic associations and then focus specifically on those diseases caused by mutations in the critical osteoclast molecule Receptor Activator of Nuclear factor Kappa B (RANK). Both loss and gain-of-function mutations have been found in humans leading to osteopetrosis and high bone turnover phenotypes, respectively. Osteopetrosis-associated RANK mutations are widely distributed over the RANK molecule. It is likely that some negatively affect ligand binding, whereas others preclude appropriate association of RANK with downstream signalling molecules. In the Paget-like disorders, familial expansile osteolysis, early onset Paget's disease and expansile skeletal hyperphosphatasia, heterozygous insertion mutations are found in the RANK signal peptide. These prevent signal peptide cleavage, trapping the protein translated from the mutated allele in the endoplasmic reticulum. Whole animal studies replicate the hyperactive osteoclast phenotype associated with these disorders and present only with heterozygous expression of the mutation, suggesting an as yet unexplained effect of the mutant allele on normal RANK function. We discuss the cell biological studies and animal models that help us to understand the nature of these different RANK defects and describe how careful dissection of these conditions can help understand critical pathways in osteoclast development and function. We highlight areas that require further study, particularly in light of the pharmacological interest in targeting the RANK signalling pathway to treat diseases caused by excessive bone resorption.
Crockett
J C
JC
Bone and Musculoskeletal Research Programme, Division of Applied Medicine, School of Medicine and Dentistry, University of Aberdeen, AB25 2ZD, Aberdeen, UK. j.c.crockett@abdn.ac.uk
Mellis
D J
DJ
Scott
D I
DI
Helfrich
M H
MH
D000818:Animals; D004195:Disease Models, Animal; D006801:Humans; D009154:Mutation; D010001:Osteitis Deformans / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D010010:Osteoclasts / Q000502:physiology*; D010022:Osteopetrosis / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D053245:RANK Ligand / Q000235:genetics / Q000502:physiology; D053246:Receptor Activator of Nuclear Factor-kappa B / Q000235:genetics / Q000502:physiology*; D015398:Signal Transduction / Q000502:physiology
D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B
Genes Dev. 2000 Apr 1;14(7):854-62
10766741
Acta Pharmacol Sin. 2009 Aug;30(8):1204-10
19578385
J Bone Miner Metab. 2004;22(6):519-23
15490260
Immunol Rev. 2005 Dec;208:106-25
16313344
J Bone Miner Res. 2005 Nov;20(11):2053-60
16234979
Mol Cell. 2009 Feb 13;33(3):275-86
19217402
Nat Genet. 2000 Jan;24(1):45-8
10615125
Histol Histopathol. 2009 Mar;24(3):337-46
19130404
Blood. 2009 Nov 12;114(20):4517-26
19762488
Nature. 1997 Feb 20;385(6618):729-33
9034190
Physiol Rev. 1999 Jul;79(3):683-701
10390516
Nat Genet. 2009 Nov;41(11):1199-206
19801982
Nature. 2008 Jun 5;453(7196):788-92
18449189
Nature. 1999 Jan 28;397(6717):315-23
9950424
Genes Dev. 1999 Apr 15;13(8):1015-24
10215628
Hum Mutat. 2010 Jan;31(1):E1071-80
19953639
Science. 1975 Nov 21;190(4216):785-7
1198094
Genes Dev. 1998 May 1;12(9):1260-8
9573043
Cell. 1997 Apr 18;89(2):309-19
9108485
Bone. 2002 Sep;31(3):366-73
12231408
J Bone Miner Res. 2007 Feb;22(2):298-309
17129176
J Clin Invest. 2007 Apr;117(4):919-30
17404618
BMC Biochem. 2007 Nov 22;8 Suppl 1:S5
18047742
J Bone Miner Res. 2008 Mar;23(3):380-91
17997709
Am J Hum Genet. 2008 Jul;83(1):64-76
18606301
Nat Cell Biol. 2005 Aug;7(8):758-65
16056267
Exp Cell Res. 1999 Sep 15;251(2):477-91
10471332
J Biol Chem. 1999 May 7;274(19):13613-8
10224132
Best Pract Res Clin Rheumatol. 2008 Mar;22(1):101-11
18328984
Science. 2000 Jun 30;288(5475):2351-4
10875917
Pediatrics. 2002 Jun;109(6):e97
12042591
Am J Hum Genet. 2003 Mar;72(3):763-71
12579474
J Bone Miner Res. 2002 Jan;17(1):26-9
11771666
Hum Mol Genet. 2000 Aug 12;9(13):2059-63
10942435
J Med Genet. 2006 Apr;43(4):315-25
16118345
J Pathol. 2007 Jan;211(2):134-43
17200947
Medicine (Baltimore). 2002 Mar;81(2):101-21
11889411
Nat Genet. 2007 Aug;39(8):960-2
17632511
Am J Pathol. 2007 Feb;170(2):427-35
17255310
Nat Genet. 2000 Jul;25(3):343-6
10888887
J Clin Invest. 2007 Jan;117(1):133-42
17187080
Lancet. 2008 Jul 12;372(9633):155-63
18620951
Hum Mol Genet. 2002 Oct 15;11(22):2735-9
12374763
J Immunol. 2010 Mar 1;184(5):2442-8
20118276
Nat Cell Biol. 2006 Apr;8(4):398-406
16547522
Hum Mol Genet. 2001 Mar 1;10(5):537-43
11181578
Bone. 2000 Sep;27(3):423-7
10962355
Ann N Y Acad Sci. 2008 Nov;1143:123-50
19076348
J Bone Miner Res. 2003 Aug;18(8):1381-5
12929927
J Biol Chem. 2007 Feb 9;282(6):3918-28
17158449
Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1566-71
10677500
Nat Genet. 2001 Mar;27(3):277-85
11242109
Science. 1997 Apr 11;276(5310):270-3
9092479
Nat Med. 1997 Nov;3(11):1285-9
9359707
Cell. 1998 Apr 17;93(2):165-76
9568710
J Clin Endocrinol Metab. 2009 Feb;94(2):691-4
18984666
Pediatr Clin North Am. 2010 Feb;57(1):171-80
20307717
J Clin Invest. 2005 Feb;115(2):200-8
15690073
Nat Genet. 2004 Apr;36(4):377-81
15034582
Nat Genet. 1999 Dec;23(4):447-51
10581033
Bone. 2000 Jan;26(1):87-93
10617161
J Bone Miner Res. 2010 Jan;25(1):20-31
19580457
J Biol Chem. 1999 Mar 19;274(12):7724-31
10075662
J Bone Miner Res. 2009 Jul;24(7):1162-72
19257814
Mol Cell Biol. 2002 Feb;22(4):992-1000
11809792
Nat Rev Mol Cell Biol. 2008 Dec;9(12):944-57
19002207
Science. 1975 Nov 21;190(4216):784-5
1105786
Calcif Tissue Int. 2009 Jan;84(1):1-12
19082854
J Clin Endocrinol Metab. 2008 Apr;93(4):1398-401
18230662
J Bone Miner Res. 2006 Mar;21(3):446-55
16491293
Dev Cell. 2004 Feb;6(2):303-9
14960283
Calcif Tissue Int. 2008 Jan;82(1):66-76
18175028
Science. 1973 May 25;180(4088):875
4706681
Clin Exp Metastasis. 2009;26(7):797-808
19590968
J Cell Biol. 2009 Dec 14;187(6):875-88
20008565
J Bone Miner Res. 2005 Apr;20(4):619-24
15765181
Cell. 2001 Jan 26;104(2):205-15
11207362
Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3597-602
9520411
J Bone Miner Res. 2009 Mar;24(3):484-94
19016598
Nature. 2009 Nov 26;462(7272):505-9
19940926
J Clin Invest. 2001 Oct;108(7):971-9
11581298
Bone. 2000 Mar;26(3):207-13
10709991
J Biol Chem. 2006 Feb 24;281(8):4678-90
16373338
J Bone Joint Surg Br. 1988 Mar;70(2):255-60
3346299
J Biol Chem. 2007 Aug 17;282(33):24131-45
17580304
Biochem Biophys Res Commun. 2007 Aug 10;359(4):1044-9
17572386
Cancer Cell. 2005 May;7(5):485-96
15894268
Nat Med. 2003 Apr;9(4):399-406
12627228
J Cell Biol. 2003 Oct 27;163(2):257-69
14581454
Cytokine. 2007 Feb;37(2):101-7
17449269
Radiology. 1985 Nov;157(2):325-7
2413500
J Med Genet. 2002 Feb;39(2):91-7
11836356
Rheumatology (Oxford). 2009 Oct;48(10):1232-5
19608727
J Bone Miner Res. 2000 Dec;15(12):2315-29
11127197
Am J Hum Genet. 2002 Jun;70(6):1582-8
11992264
Am J Med Genet. 1989 Sep;34(1):43-54
2683780
Bone. 2001 May;28(5):513-23
11344051
J Exp Med. 1999 Dec 20;190(12):1741-54
10601350
Trends Mol Med. 2006 Jul;12(7):306-16
16782405
Genes Cells. 1999 Jun;4(6):353-62
10421844
PLoS Biol. 2006 Nov;4(12):e423
17132049
Science. 1997 Apr 11;276(5310):266-9
9092478
Clin Orthop Relat Res. 1984 Oct;(189):239-63
6434217
J Biol Chem. 2001 Aug 10;276(32):30011-7
11406619
N Engl J Med. 2002 Jul 18;347(3):175-84
12124406
Hum Mol Genet. 2007 Apr 15;16(8):919-28
17329348
Hum Mol Genet. 2002 Sep 1;11(18):2119-27
12189164
Arch Biochem Biophys. 2008 May 15;473(2):172-82
18359282
J Biol Chem. 2006 May 19;281(20):13964-71
16547002
Cell. 2008 Feb 8;132(3):344-62
18267068
Proc Natl Acad Sci U S A. 1983 May;80(9):2752-6
6405388
Ann Intern Med. 2009 Oct 20;151(8):528-37
19841454
Science. 1996 Aug 30;273(5279):1236-8
8703060
Genes Dev. 1999 Sep 15;13(18):2412-24
10500098